Zoltan Dekan
A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor
Dekan, Zoltan; Sianati, Setareh; Yousuf, Arsalan; Sutcliffe, Katy J.; Gillis, Alexander; Mallet, Christian; Singh, Paramjit; Jin, Aihua H.; Wang, Anna M.; Mohammadi, Sarasa A.; Stewart, Michael; Ratnayake, Ranjala; Fontaine, Frank; Lacey, Earnest; Piggott, Andrew M.; Du, Yan P.; Canals, Meritxell; Sessions, Richard B.; Kelly, Eamonn .; Capon, Robert J.; Alewood, Paul F.; Christie, MacDonald J.
Authors
Setareh Sianati
Arsalan Yousuf
Katy J. Sutcliffe
Alexander Gillis
Christian Mallet
Paramjit Singh
Aihua H. Jin
Anna M. Wang
Sarasa A. Mohammadi
Michael Stewart
Ranjala Ratnayake
Frank Fontaine
Earnest Lacey
Andrew M. Piggott
Yan P. Du
MERITXELL CANALS M.CANALS@NOTTINGHAM.AC.UK
Professor of Cellular Pharmacology
Richard B. Sessions
Eamonn . Kelly
Robert J. Capon
Paul F. Alewood
MacDonald J. Christie
Abstract
An Australian estuarine isolate ofPenicilliumsp. MST-MF667 yielded3 tetrapeptides named the bilaids with an unusual alternating LDLDchirality. Given their resemblance to known short peptide opioidagonists, we elucidated that they were weak (Kilow micromolar)?-opioid agonists, which led to the design of bilorphin, a potent andselective?-opioid receptor (MOPr) agonist (Ki1.1 nM). In sharp con-trast to all-natural product opioid peptides that efficaciously recruit?-arrestin, bilorphin is G protein biased, weakly phosphorylatingthe MOPr and marginally recruiting?-arrestin, with no receptorinternalization. Importantly, bilorphin exhibits a similar G proteinbias to oliceridine, a small nonpeptide with improved overdosesafety. Molecular dynamics simulations of bilorphin and thestrongly arrestin-biased endomorphin-2 with the MOPr indicatedistinct receptor interactions and receptor conformations thatcould underlie their large differences in bias. Whereas bilorphinis systemically inactive, a glycosylated analog, bilactorphin, isorally active with similar in vivo potency to morphine. Bilorphinis both a unique molecular tool that enhances understanding ofMOPr biased signaling and a promising lead in the development ofnext generation analgesics.
Citation
Dekan, Z., Sianati, S., Yousuf, A., Sutcliffe, K. J., Gillis, A., Mallet, C., …Christie, M. J. (2019). A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor. Proceedings of the National Academy of Sciences, 116(44), 22353-22358. https://doi.org/10.1073/pnas.1908662116
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 18, 2019 |
Online Publication Date | Oct 14, 2019 |
Publication Date | Oct 29, 2019 |
Deposit Date | Sep 23, 2019 |
Publicly Available Date | Oct 14, 2019 |
Journal | Proceedings of the National Academy of Sciences |
Print ISSN | 0027-8424 |
Electronic ISSN | 1091-6490 |
Publisher | National Academy of Sciences |
Peer Reviewed | Peer Reviewed |
Volume | 116 |
Issue | 44 |
Pages | 22353-22358 |
DOI | https://doi.org/10.1073/pnas.1908662116 |
Keywords | Multidisciplinary |
Public URL | https://nottingham-repository.worktribe.com/output/2648835 |
Publisher URL | https://www.pnas.org/content/early/2019/10/08/1908662116 |
Files
2019-08662R Merged PDF
(1.5 Mb)
PDF
Supplementary information: Biased ?-opioid analgesics derived from a novel tetrapeptide class found in an Australian fungus
(1.7 Mb)
PDF
You might also like
Opioid pharmacology under the microscope
(2020)
Journal Article
GRK mediates ?-opioid receptor plasma membrane reorganization
(2019)
Journal Article